Patents Examined by Sean Basquill
  • Patent number: 9867800
    Abstract: A method of quenching excited state energy from a pigment that has been excited by absorption of light having a wavelength in the wavelength range of 290-800 nm, comprising reacting a pigment with a conjugated fused tricyclic compound having electron withdrawing groups: of Formula (II) or a salt thereof: wherein: A is selected from the group consisting of O, S, C?O, C?S, and B1, B2, D1, and D2 are each independently selected from the group consisting of F, Cl, Br, I, CF3, CCl3, NR33+, NO2, CN, C(?O)R4, C(?O)OR1, SO2R5, aryl, and —C?CHR6; each m independently is 0, 1, 2, 3, or 4; n is 0 or 1; each R1 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, and aryl; R2 is selected from the group consisting of H, alkyl, cycloalkyl, alkenyl, alkynyl, and aryl; each R3 is independently selected from the group consisting of H and C1-C6 alkyl; each R4 is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cyc
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: January 16, 2018
    Assignee: Hallstar Innovations Corp.
    Inventors: Craig A. Bonda, Shengkui Hu
  • Patent number: 9808498
    Abstract: The invention relates to a composition for pharmaceutical or nutritional or cosmetic use, formulated for oral or topical use and possessing antioxidant activity against free radicals, comprising: a) a Vitis vinifera seed, or seed and leaf, extract containing a combination of the flavonoids catechin and quercetin in a molar ratio in a range from 6:1 to 3:1, respectively, or a?) a Vitis vinifera seed, or seed and leaf, extract containing a combination of the flavonoids catechin and quercetin in a molar ratio in a range from 7:1 to 4:1, respectively, or a?) a mixture of Vitis vinifera extracts a) and a?), or a??) a mixture of catechin and quercetin in a molar ratio in a range from 7:1 to 3:1, respectively, together with b) an olive, Olea europaea L, leaf extract having a hydroxytyrosol content in a range from 1% to 30% by weight of the extract, or b?) hydroxytyrosol in an amount equal to that contained in the b) extract.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: November 7, 2017
    Assignee: Giuliani S.p.A.
    Inventors: Giammaria Giuliani, Anna Benedusi, Barbara Marzani, Antonio Mascolo, Antonio Limitone, Sergio Baroni
  • Patent number: 9801794
    Abstract: The present invention relates to inorganic powder coated with biocompatible polymer and a cosmetic composition comprising same. More particularly, the present invention relates to an organic/inorganic composite powder in which the rough surface of the inorganic powder is treated with biocompatible polymer, thereby improving dispersibility and feeling of use and to a cosmetic composition comprising said composite powder so as to achieve improved feeling of use and tight adhesion when applied to the skin.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: October 31, 2017
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Hyun Suk Lee, Jun Oh Kim, Young Jun Yang, Song Seok Shin, Kyung Ho Choi, Yeong Jin Choi, Young Ho Park
  • Patent number: 9801355
    Abstract: The present invention relates to a pesticidal control device that includes at least one pesticidal active ingredient, cellulose fibers, and a polymer or polymer matrix. The combination of the cellulose fibers with the polymer allows for a higher loading of liquid pesticidal active ingredients within the pesticidal control device, maintains the active ingredient within the control device during transportation, storage and handling, and provides higher efficacy or control of pests during treatment. The pesticidal control device may be an ear tag, collar, or bee strip.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: October 31, 2017
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Robert G. Pennington, John Rose, Jochem Rueter
  • Patent number: 9757314
    Abstract: The present invention relates to carriers for the controlled release of active agents, comprising surface reacted natural or synthetic calcium carbonate, one or more active agents, wherein said one or more active agent is associated with said surface-reacted calcium carbonate, and wherein said surface-reacted natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source. It further relates to the preparation of loaded carriers, as well as their use in different applications.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: September 12, 2017
    Assignee: Omya International AG
    Inventors: Patrick A. C. Gane, Joachim Schoelkopf
  • Patent number: 9744107
    Abstract: The present invention relates to carriers for the controlled release of active agents, comprising surface reacted natural or synthetic calcium carbonate, one or more active agents, wherein said one or more active agent is associated with said surface-reacted calcium carbonate, and wherein said surface-reacted natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source. It further relates to the preparation of loaded carriers, as well as their use in different applications.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: August 29, 2017
    Assignee: Omya International AG
    Inventors: Patrick A. C. Gane, Joachim Schölkopf
  • Patent number: 9707240
    Abstract: The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a large lipid globule size. The composition can be used to prevent obesity and/or improve body composition later in life.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: July 18, 2017
    Assignee: N.V. Nutricia
    Inventors: Antonie Van Baalen, Eline Marleen Van Der Beek, Christopher Beermann, Günther Boehm
  • Patent number: 9707417
    Abstract: Described is the use of benzotropolone and their derivatives, especially the compounds of formula (1); wherein R2, R3, R4, R5 and R6 independently of one another are hydrogen; OH; C1-C30alkyl, C2-C30al-kenyl, C1-C30alkoxy, C3-C12cycloalkyl or C1C30hydroxyalkyl, which may be substituted by one or more E and/or interrupted by one or more D; C6-C20aryl, which may be substituted by one or more G; C4-C20heteroaryl, which may be substituted by one or more G, C2-C18alkenyl, C2-C18alkynyl, C7-C25aralkyl, CN, or —CO—R17; C1-C30mono- or dialkylamino; COR9; COOR9; CONR9R10; CN; SO2R9; OCOOR9; OCOR9; NHCOOR9; NR9COR10; NH2; *—(CO)—NH—(CH2)n1—(PO)—(OR11)2; —(CO)—O—(CH2)n1—(PO)—(OR11)2; sulphate; sulphonate; phosphate; phosphonate; —(CH2)n2—[O—(SO2)]n3—OR11; —O—(CH2)n4(CO)n5—R11; —(O)n6—(CH2)n7—(PO)—(OR9)2; —(O)n6—(CH2)n7—SO2—OR9; halogen; organosilanyl; organo-siloxanyl; or a sugar residue linked directly in an ?- or ?-mode via the anomeric oxygen to the benzotropolone system or via a linear or branched alkylene, alkenyle
    Type: Grant
    Filed: June 18, 2009
    Date of Patent: July 18, 2017
    Assignee: BASF SE
    Inventors: Barbara Wagner, Reinhold Öhrlein, Bernd Herzog, Kai Eichin, Gabriele Baisch, Stephanie Portmann
  • Patent number: 9707178
    Abstract: A pharmaceutical composition comprising an ester of 4-(1-hydroxy-1-methylethyl)-2 propyl-1-[[2?-(1H-tetrazol-5-yl)[1,1?-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid characterized in that when exposed to 75% relative humidity at 40° in open dish for one month the total amount of related substances does not increase more than 1% is described.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: July 18, 2017
    Assignee: Lek Pharmaceuticals, d.d.
    Inventors: Matej Avanzo, Tanja Rozman Peterka, Igor Legen
  • Patent number: 9700568
    Abstract: The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a lipid globules coated with polar lipids. The composition can be used to prevent obesity and/or improve body composition later in life.
    Type: Grant
    Filed: April 5, 2016
    Date of Patent: July 11, 2017
    Assignee: N.V. Nutricia
    Inventors: Eline Marleen Van Der Beek, Marieke Abrahamse-Berkeveld, Günther Boehm, Antonie Van Baalen
  • Patent number: 9700545
    Abstract: The present invention relates to Rifaximin amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: July 11, 2017
    Assignee: Salix Pharmaceuticals, Ltd
    Inventors: Karen S. Gushurst, Donglai Yang, Melanie Janelle Bevill, Nathan Carl Schultheiss, Giuseppe Claudio Viscomi
  • Patent number: 9682988
    Abstract: Solid forms of certain opioid agonists are provided herein. Methods of preparing the solid forms, methods of using the solid forms, and pharmaceutical compositions comprising the solid forms are also provided herein.
    Type: Grant
    Filed: October 29, 2013
    Date of Patent: June 20, 2017
    Assignee: Nektar Therapeutics
    Inventors: Patricia Andres, Yogesh Datar, Ramakrishna Gadiraju, Bruce Andrew Kowalczyk, Gabriel Christian Kuklis, Mahmoud Mirmehrabi, Nicholas Paschalides
  • Patent number: 9675729
    Abstract: The invention refers to an active polymer layer (1) especially for a dressing of a three-dimensional structure characterized in that it has non-fibrous structure made of chitin derivatives obtained in the esterification reaction of chitin in the presence of aliphatic anhydrides of a chain of a length from C2 to C8 straight saturated, and anhydrides preferably, acetic-propionic anhydride, butanoic-propionic anhydride, branched unsaturated anhydrides preferably, methacrylic anhydride, 2-butenoic anhydride and cyclic preferably, maleic anhydride, succinic anhydride, phthalic anhydride) and hydroxyacids preferably, lactic acid, glycolic acid, which can comprise additionally fibroblasts (6) and/or keratinocytes (7) and is used for producing dressing which can be applied on affected areas, including clean, flat shallow ulcerations characterised by modifiable granulations, the patent femoral artery with mild and moderate deficiency and no intensive exudation.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: June 13, 2017
    Assignee: CELTHER POLSKA SP. ZO.O.
    Inventors: Piotr Rieske, Ewelina Stoczynska-Fidelus, Karolina Skolucka, Sylwester Piaskowski
  • Patent number: 9675611
    Abstract: A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C12/Cmax ratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: June 13, 2017
    Assignee: Purdue Pharma L.P.
    Inventors: Benjamin Oshlack, Hua-Pin Huang, John Masselink, Alfred Tonelli
  • Patent number: 9675558
    Abstract: An oral cyclosporin composition comprises minicapsules having a core containing a cyclosporin, especially cyclosporin A in a solubilised liquid form. The minicapsules have a release profile to release the pre-solubilised cyclosporin, at least in the colon. The composition may be used for treating a range of intestinal diseases.
    Type: Grant
    Filed: February 23, 2016
    Date of Patent: June 13, 2017
    Assignee: Sigmoid Pharma Limited
    Inventor: Ivan Coulter
  • Patent number: 9668997
    Abstract: Ophthalmic compositions including compatible solute components and/or polyanionic components are useful in treating eyes, for example, to relieve dry eye syndrome, to protect the eyes against hypertonic insult and/or the adverse effects of cationic species on the ocular surfaces of eyes and/or to facilitate recovery from eye surgery.
    Type: Grant
    Filed: January 4, 2016
    Date of Patent: June 6, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Joseph G. Vehige, Peter A. Simmons, Joan-En Chang-Lin
  • Patent number: 9669024
    Abstract: A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C12/Cmax ratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: June 6, 2017
    Assignee: Purdue Pharma L.P.
    Inventors: Benjamin Oshlack, Hua-Pin Huang, John Masselink, Alfred Tonelli
  • Patent number: 9669022
    Abstract: A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C12/Cmax ratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: June 6, 2017
    Assignee: Purdue Pharma L.P.
    Inventors: Benjamin Oshlack, Hua-Pin Huang, John Masselink, Alfred Tonelli
  • Patent number: 9663411
    Abstract: A soil additive comprising a sugar ferment wherein said ferment contains signalling molecules comprising between about 1-50% of the organic matter present in the ferment.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: May 30, 2017
    Assignee: LIQUID FERTILISER SYSTEMS PTY LTD
    Inventor: Peter James Keating
  • Patent number: 9656001
    Abstract: A non-synthetic, hydrophilic, biodegradable, biocompatible polysaccharide based non-toxic anti-adhesion hydrogel barrier is disclosed herein. The barrier of the present invention is formed by constructing a unique interpenetrating, crosslinked network with a unique porosity. Furthermore, the barrier of the present invention is comprised of tunable biopolymers for controllable mechanical robustness and degradation. The barrier of the present invention effectively reduces unwanted adhesions using non-synthetic components.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: May 23, 2017
    Assignee: Board of Regents, The University of Texas System
    Inventors: Sarah Mayes, Christine E. Schmidt